Latest filing published 29 Jun 2021 for Elevation Oncology, Inc., €3.4M.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Vertex Global HC Fund II Pte. Ltd.: trading record in brief
Vertex Global HC Fund II Pte. Ltd. discloses dealings in Elevation Oncology, Inc. to SEC (Form 4). We count 3 filings, every one of them for a trade on 29 June 2021.
The open-market record is one-sided, with 1 purchase worth €3.4M and not one sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
The record was last updated on 29 June 2021 with an open-market purchase (€3.4M) in Elevation Oncology, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Vertex Global HC Fund II Pte. Ltd.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 250,000 shares@ US$16.00100.0% of flowCommon StockSEC:0001104659-21-086828:2Canonical exit: 27 Sept 2021 (T+90)
- 401,065 sharesCommon StockSEC:0001104659-21-086828:1
- 1,656,577 sharesCommon StockSEC:0001104659-21-086828:0
3 of 3 declarations